Literature DB >> 9226793

Patients' and professionals' understandings of the causes of chronic pain: blame, responsibility and identity protection.

C Eccleston1, A C Williams, W S Rogers.   

Abstract

A social constructionist analysis of how sense is made of the causes of chronic pain is reported. It is recognised that there is a multiplicity of stories available in any culture from which understanding can be reached. Q-factor analysis is used within a critical framework as Q-methodology. Sixty chronic pain patients and pain professionals completed the sorting procedure. Four factors were derived that account for the causes of chronic pain. These are reported as the patients' account, the professionals' account, the scientists account and the alternative practitioner's account. Common to all four accounts are the themes of responsibility, blame and the need to protect identity. It is argued that in all accounts responsibility is repositioned away from the sufferer or the healer. In all of the accounts blame is resisted or deflected away from individual ownership. Finally, it is argued that when pain is no longer useful as a symptom, identity is challenged, weakened and at risk for both chronic pain patients and pain professionals. Implications of this study for chronic pain research and treatment are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9226793     DOI: 10.1016/s0277-9536(96)00404-2

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  24 in total

1.  The "self" in pain: the role of psychological inflexibility in chronic pain adjustment.

Authors:  Silvia Sze Wai Kwok; Esther Chin Chi Chan; Phoon Ping Chen; Barbara Chuen Yee Lo
Journal:  J Behav Med       Date:  2016-06-08

2.  Opioids, chronic pain, and addiction in primary care.

Authors:  Declan T Barry; Kevin S Irwin; Emlyn S Jones; William C Becker; Jeanette M Tetrault; Lynn E Sullivan; Helena Hansen; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  J Pain       Date:  2010-06-02       Impact factor: 5.820

3.  Explaining unexplained pain to fibromyalgia patients: finding a narrative that is acceptable to patients and provides a rationale for evidence based interventions.

Authors:  Michael E Hyland; Claire Hinton; Charlotte Hill; Ben Whalley; Rupert Cm Jones; Anthony F Davies
Journal:  Br J Pain       Date:  2016-04-11

4.  Effect of treatment success and empathy on surgeon attributions for back surgery outcomes.

Authors:  Raymond C Tait; John T Chibnall; Angela Luebbert; Christian Sutter
Journal:  J Behav Med       Date:  2005-08

5.  Can images of pain enhance patient-clinician rapport in pain consultations?

Authors:  Claire E Ashton-James; Peter H Dekker; Judy Addai-Davis; Tom Chadwick; Joanna M Zakrzewska; Deborah Padfield; Amanda C de C Williams
Journal:  Br J Pain       Date:  2017-06-26

6.  What affects return to work for graduates of a pain management program with chronic upper limb pain?

Authors:  Jacqueline H Adams; Amanda C de C Williams
Journal:  J Occup Rehabil       Date:  2003-06

7.  The (gendered) construction of diagnosis interpretation of medical signs in women patients.

Authors:  K Malterud
Journal:  Theor Med Bioeth       Date:  1999-06

8.  A qualitative study of perceived responsibility and self-blame in type 2 diabetes: reflections of physicians and patients.

Authors:  Elizabeth A Beverly; Marilyn D Ritholz; Kelly M Brooks; Brittney A Hultgren; Yishan Lee; Martin J Abrahamson; Katie Weinger
Journal:  J Gen Intern Med       Date:  2012-05-02       Impact factor: 5.128

9.  The process of acceptance among rheumatoid arthritis patients in Switzerland: a qualitative study.

Authors:  Zlatina Kostova; Maria Caiata-Zufferey; Peter J Schulz
Journal:  Pain Res Manag       Date:  2014-02-13       Impact factor: 3.037

10.  Disease rarity, carrier status, and gender: a triple disadvantage for women with Fabry disease.

Authors:  Andrea L Gibas; Regan Klatt; Jack Johnson; Joe T R Clarke; Joel Katz
Journal:  J Genet Couns       Date:  2008-10-16       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.